Insights from 2023 ASH Annual Meeting
D

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis

By Insights from 2023 ASH Annual Meeting FEATURING Douglas Tremblay
By Insights from 2023 ASH Annual Meeting FEATURING Douglas Tremblay
425 views
December 13, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Content

AUTOPLAY
24:08

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

1.4K views
24:35

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

1.2K views
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

635 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

866 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

884 views
16:18

Masterclasses from the Wards

Masterclasses in Dermatology

S. Elman

312 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

334 views
37:21

New Approval for Frontline Consolidation in Patients with CD19-posit…

Amgen Sponsorship

J. Mccloskey

481 views
27:37

Review of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

2.7K views
18:04

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

Ruben Mesa

930 views
06:00

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

2024 Clinical Case Studies

A. Geisler

616 views
06:18

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Avai…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

283 views
16:51

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Incyte

C. Harrison

410 views
31:12

Practice-Changing Abstracts in NHL and HL From ASH 2023

UChicago Medicine

S. Smith

398 views
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

94 views
17:07

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Mana…

2024 ASCO® Annual Meeting Insights Hub

M. Minnema

274 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

290 views
40:38

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

240 views
24:48

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Indy Hematology Review

R. Rampal

315 views
21:52

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…

Insights from 2023 ASH Annual Meeting

D. Tremblay

401 views